Gary Liska, with Alere Home Monitoring Inc, says Alere's commitment to patients' safety is why they supported the STABLE study.
Gary Liska, with Alere Home Monitoring Inc, says Alere’s commitment to patient safety is why they supported the STABLE study. They saw an opportunity with Medicare’s expansion of its coverage policy for self-testing, and decided to provide self-testing services to Medicare and practitioners.
Mr Liska also explains why the STABLE study results are so important.
“Within the last 3 years, there have been 5 clinical papers written on cost-effectiveness. The market remains very volatile right now, and clinicians, and particularly healthcare, is looking for the most cost-effective agent,” Mr Liska says. “The 5 studies that have been published are all consistent with a certain threshold of warfarin quality of between 65% and 73%, so those are thresholds that Alere looks at very carefully. It was really the impetus behind conducting this study.”
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More